First-in-class oral small molecule inhibitor of the tyrosine kinase ROR1 (KAN0439834) induced significant apoptosis of chronic lymphocytic leukemia cells.
作者信息
Hojjat-Farsangi M, Daneshmanesh A H, Khan A S, Shetye J, Mozaffari F, Kharaziha P, Rathje L-S, Kokhaei P, Hansson L, Vågberg J, Byström S, Olsson E, Löfberg C, Norström C, Schultz J, Norin M, Olin T, Österborg A, Mellstedt H, Moshfegh A
机构信息
Department of Oncology-Pathology, Immune and Gene Therapy Lab, CancerCenterKarolinska (CCK), Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden.
Kancera AB, Solna, Sweden.
出版信息
Leukemia. 2018 Oct;32(10):2291-2295. doi: 10.1038/s41375-018-0113-1. Epub 2018 Mar 27.
Abstract
摘要
Zotero 插件